Navigation Links
Biopure Exploring Strategic Options
Date:2/17/2009

Earnings for year ended October 31, 2008, contained in Annual Report filed on February 13, 2009, with Going Concern Modification

CAMBRIDGE, Mass., Feb. 17 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) announced today that it is exploring strategic options for financing or alternative transactions. The company has engaged Newbury Piret & Co. to advise on options, including evaluation of nonbinding proposals that have been received. There should be no assumption that this process will result in any transaction or any particular type of transaction.

On February 13, 2009, the company filed with the SEC its Annual Report on Form 10-K, which contains the company's financial statements for the two years ended October 31, 2008. The company does not intend to issue a separate earnings release. The report of the company's independent registered public accounting firm contained in this filing is modified with respect to the company's ability to continue as a going concern.

Biopure Corporation

Biopure Corporation develops pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues. Hemopure(R) [hemoglobin glutamer - 250 (bovine)], or HBOC-201, is approved for sale in South Africa for the treatment of surgical patients who are acutely anemic. On November 21, 2008, the company announced that it had terminated most of its work force for financial reasons. Using its limited resources, the company is supporting the U.S. Navy's government-funded efforts to develop a potential out-of-hospital trauma indication. Biopure's veterinary product Oxyglobin(R) [hemoglobin glutamer - 200 (bovine)], or HBOC-301, the only oxygen therapeutic approved for marketing by both the U.S. Food and Drug Administration and the European Commission,
'/>"/>

SOURCE Biopure Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance
2. Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia
3. Biopure Sues National Institutes of Health Official
4. Agency Takes Adverse Decision to Biopures Product Registration in South Africa
5. Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance
6. Biopure Reaffirms Strategy Following Recent NIH/FDA Workshop
7. Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
8. Biopure Announces 2007 Fourth Quarter and Year-End Financial Results
9. Four Abstracts by Biopure and Collaborating Scientists Accepted for Annual Meeting of American Society for Clinical Pharmacology and Therapeutics
10. Biopure Announces Closing of $14.9 Million Financing
11. Biopures Stock Symbol Reverts to BPUR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... California (PRWEB) October 20, 2014 Final Cut ... the release of the Citrus theme for FCPX filmmakers ... would use to describe the Citrus theme” Says Christina Austin, ... easy to look so professional.” , Citrus comes with all ... with the template are: four transitions for added style, a ...
(Date:10/20/2014)... October 20, 2014 Houston plastic surgeon ... the key elements of his innovative True Form ... plastic surgery residents and faculty at The University ... he, too, was once a medical student. Patronella, who ... private cosmetic plastic surgery practices in Texas, The ...
(Date:10/19/2014)... Recently, BambooIndustry.com, one of the most popular suppliers of ... bamboo deckings . Moreover, the company has launched a ... available at deeply discounted rates. , As is ... the significance of online business nowadays. Thus, BambooIndustry.com pays ... workers are striving to deliver both value and efficiency ...
(Date:10/19/2014)... Recently, Top10BestSEOHosting.com has unveiled its newest ... and HostMonster are the best VPS hosting suppliers ... is the method of partitioning a physical server ... the appearance and capabilities of running on someone’s ... pays close attention to VPS products and related ...
(Date:10/19/2014)... Stephen T. Greenberg, M.D., with offices in Woodbury, Southampton and ... as one of Long Island’s best cosmetic surgeons. In ... the best provider for Botox injections. Glisten, his Skin & ... best Laser Treatment center on Long Island.* , The voting ... the contest once per day, per IP address. , Stephen ...
Breaking Medicine News(10 mins):Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2
... Feb. 12 After Phil Cohen, president of ... interview last year, he signed on to do ... introduced those videos this week via PRN Funding,s ... formal launch of its YouTube Channel in place, ...
... Altmeyer brings extensive experience in neuroscience and oncology ... these therapeutic categories , , ROCKVILLE, ... America Pharmaceutical, Inc. (OAPI), a fast-growing health care ... in North America, has announced the appointment of ...
... Earns Milestone Payment of Additional $2.5 MillionCRANBURY, N.J., ... US: PTN) today announced it has received $4.1 ... its exclusive research collaboration and license agreement to ... receptors and a clinical trial sponsored research agreement. ...
... N.J., Feb. 12 DOR BioPharma, Inc. (OTC Bulletin ... it has signed a potential $30 million partnering agreement ... for the development and commercialization in North America of ... the agreement, Sigma - Tau will make a $6 ...
... Will Now Be Available to a Wider Medical Market through Nation,s ... ... 2009 -- Inviro Medical Devices, an industry leader in infection control ... of the nation,s largest and most respected GPOs, or group provider ...
... Montgomery law firm prevails on behalf of plaintiff in medical malpractice lawsuit ... hours of deliberations , ... Santa Rosa, Calif. (Lexis Nexis) February 12, ... the Santa Rosa law firm of Teal & Montgomery, scored a major ...
Cached Medicine News:Health News:PRN Funding Introduces the PRN Funding YouTube Channel 2Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 2Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 3Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 4Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 5Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 6Health News:Palatin Technologies Announces Receipt of $4.1 Million from AstraZeneca 2Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 2Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 3Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 4Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 5Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 6Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 7Health News:Inviro Medical Devices Is Awarded a Three Year Contract with Leading GPO Novation 2Health News:Steve Teal, Santa Rosa Attorney, Obtains $850,000 for Client in Highest Hospital Negligence Verdict in Mendocino County 2
(Date:10/17/2014)... BALTIMORE , Oct. 17, 2014  Ameritox SM ... announced the appointment of Thomas Smith , M.D., ... lead a field-based team offering scientific resources for healthcare ... Smith has held leadership positions at a variety of ... will benefit both the pain and behavioral health sides ...
(Date:10/17/2014)... --  ndd Medical Technologies , a leader in innovative ... announced that its EasyOne Pro® is now being used ... 140,000 square foot, 44-bed hospital with many outpatient services. ... a large number of Native Americans from several tribes ... beyond. A portion of its funding comes from the ...
(Date:10/17/2014)... 2014  STAAR Surgical Company (NASDAQ: STAA ), ... systems for the eye, today announced that the Company will ... October 18, 7:00 a.m. CT at the American Academy of ... Dr. Erik Mertens , Medical Director ... Antwerp, Belgium , will present his first cases with ...
Breaking Medicine Technology:Ameritox Appoints New Chief Medical Officer 2EasyOne Pro Mobile Respiratory Testing from ndd Medical Technologies Chosen by Choctaw Nation 2STAAR Surgical to Webcast Investor Presentations at American Academy of Ophthalmology's Annual Meeting 2STAAR Surgical to Webcast Investor Presentations at American Academy of Ophthalmology's Annual Meeting 3
... Reportlinker.com announces that a new market ... Medical Imaging Markets: ... http://www.reportlinker.com/p0790439/Medical-Imaging-Markets-MRI-Magnetic-Resonance-Imaging-and-Ultrasound-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ... and potential world market for medical MRI ...
... SAN DIEGO, March 7, 2012   OncoSec Medical ... OncoSec Medical System (OMS) ElectroOncology therapies to treat ... Bhatia, Principal Investigator for the company,s Phase II ... a local Seattle news outlet, The Journal ...
Cached Medicine Technology:Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 2Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 3Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 4Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 5Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 6Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 7Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 8Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 9OncoSec's OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma Clinical Trial Featured in Seattle Newspaper 2OncoSec's OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma Clinical Trial Featured in Seattle Newspaper 3OncoSec's OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma Clinical Trial Featured in Seattle Newspaper 4
Sealing tape featuring 3M adhesive technology. Opaque and strong. Prevents photo-degradation....
Sealing tape featuring 3M adhesive technology. Compatible with DMSO. Good optical quality. Minimal autofluorescence....
Empore Sealing Tape Pads are ideal for covering a 96 well plate during storage or transfer to another work station. Not intended for use with auto-injectors....
... 'A' film is a quick and effective means ... plates and tubes. The compliant inner layer is ... smoothly. This minimizes the risk of aerosol formation ... cut for use with fewer than 96 wells, ...
Medicine Products: